A comprehensive view of Tandem Diabetes Care Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Tandem Diabetes Care Q1 net loss widens to US$14.7M from US$5.0M a year ago, with sales up 25% year-over-year to US$175.9M; FDA clears t:slim X2 insulin pump to bolus with t:connect mobile app, with global pump shipments growing 11% to 28,095 pumps

Tandem Diabetes Care announces FDA clearnace of the t:slim X2 Insulin Pump using the t:connect mobile app; combination enables diabetes patients to program the insulin dosing solution

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count